Warning letter
Crown Laboratories, Inc.: warning letter of Feb 28, 2003
FDA warning letter UCM147338 · Nashville District Office
Key facts
| Reference number | UCM147338 |
|---|---|
| Company | Crown Laboratories, Inc. |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Feb 28, 2003 |
| Posted date | Feb 28, 2003 |
| Issuing office | Nashville District Office |
| Product type | Drugs |
| CFR sections cited | 211.67(b), 211.165(d), 211.80, 211.110, 211.122, 211.166, 211.186, 211.198 |
| Country | 3 |
| Inspection city | Johnson City |
| Inspection ZIP | 37604-7469 |
| Inspection start date | Jan 7, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: